@pgrivasmdphd.bsky.social
1/ Best practices for 2L+ tx #MetastaticUrothelialCarcinoma 🧵
w🌟 @tiansterzhangmd.bsky.social & me
...assuming EV+P 1L
✅FGFR3 alts: THOR/erda
🎯Trop-2: sacituzumab govitecan
🏁HER2 IHC 3+: T-DXd
Support by edu grants: Astellas, Gilead Sci, Merck, Seagen
#CME from @bonumce.bsky.social ℹ️👇
w🌟 @tiansterzhangmd.bsky.social & me
...assuming EV+P 1L
✅FGFR3 alts: THOR/erda
🎯Trop-2: sacituzumab govitecan
🏁HER2 IHC 3+: T-DXd
Support by edu grants: Astellas, Gilead Sci, Merck, Seagen
#CME from @bonumce.bsky.social ℹ️👇
April 1, 2025 at 11:38 PM
1/ Best practices for 2L+ tx #MetastaticUrothelialCarcinoma 🧵
w🌟 @tiansterzhangmd.bsky.social & me
...assuming EV+P 1L
✅FGFR3 alts: THOR/erda
🎯Trop-2: sacituzumab govitecan
🏁HER2 IHC 3+: T-DXd
Support by edu grants: Astellas, Gilead Sci, Merck, Seagen
#CME from @bonumce.bsky.social ℹ️👇
w🌟 @tiansterzhangmd.bsky.social & me
...assuming EV+P 1L
✅FGFR3 alts: THOR/erda
🎯Trop-2: sacituzumab govitecan
🏁HER2 IHC 3+: T-DXd
Support by edu grants: Astellas, Gilead Sci, Merck, Seagen
#CME from @bonumce.bsky.social ℹ️👇
Reposted
This GU oncology family — wonderful first #AUC3 consensus conference!
@drchoueiri.bsky.social @pgrivasmdphd.bsky.social @davidaggen.bsky.social
@drchoueiri.bsky.social @pgrivasmdphd.bsky.social @davidaggen.bsky.social
January 24, 2025 at 4:08 AM
This GU oncology family — wonderful first #AUC3 consensus conference!
@drchoueiri.bsky.social @pgrivasmdphd.bsky.social @davidaggen.bsky.social
@drchoueiri.bsky.social @pgrivasmdphd.bsky.social @davidaggen.bsky.social
Reposted
Expanded indication for TDXd!
The FDA has approved trastuzumab deruxtecan (T-DXd) for patients with HR-positive, HER2-low, or HER2-ultralow metastatic breast cancer based on DESTINY-Breast06 trial results. #BreastCancer #Oncology ascopost.com/news/january...
January 31, 2025 at 11:03 AM
Expanded indication for TDXd!
Reposted
Happy New Year from OncoAlert
@jrgralow.bsky.social
@elisabettabonzano.bsky.social
@stolaney1.bsky.social
@stoverlab.bsky.social
@pgrivasmdphd.bsky.social
@axelmerseburger.bsky.social
@drnataliagandur.bsky.social
@biagioricciutimd.bsky.social
@fernandoonco.bsky.social
@jrgralow.bsky.social
@elisabettabonzano.bsky.social
@stolaney1.bsky.social
@stoverlab.bsky.social
@pgrivasmdphd.bsky.social
@axelmerseburger.bsky.social
@drnataliagandur.bsky.social
@biagioricciutimd.bsky.social
@fernandoonco.bsky.social
January 1, 2025 at 5:17 AM
Reposted
Awesome panel moderated by #MontyPal #BradMcGregor for non clear cell #Kidneycancer. Histology matters! And so do molecular markers! #AUC3
@drchoueiri.bsky.social @pgrivasmdphd.bsky.social @davidaggen.bsky.social @erplimackmd.bsky.social
@drchoueiri.bsky.social @pgrivasmdphd.bsky.social @davidaggen.bsky.social @erplimackmd.bsky.social
January 23, 2025 at 9:08 PM
Awesome panel moderated by #MontyPal #BradMcGregor for non clear cell #Kidneycancer. Histology matters! And so do molecular markers! #AUC3
@drchoueiri.bsky.social @pgrivasmdphd.bsky.social @davidaggen.bsky.social @erplimackmd.bsky.social
@drchoueiri.bsky.social @pgrivasmdphd.bsky.social @davidaggen.bsky.social @erplimackmd.bsky.social
Reposted
Redefining first-line options for advanced urothelial carcinoma! Insights on platinum chemotherapy, immunotherapy combos, and patient-tailored strategies. @tiansterzhangmd.bsky.social @oncoalert.bsky.social @oncbrothers.bsky.social
#Oncology #BladderCancer
#Oncology #BladderCancer
December 9, 2024 at 8:40 PM
Redefining first-line options for advanced urothelial carcinoma! Insights on platinum chemotherapy, immunotherapy combos, and patient-tailored strategies. @tiansterzhangmd.bsky.social @oncoalert.bsky.social @oncbrothers.bsky.social
#Oncology #BladderCancer
#Oncology #BladderCancer
Reposted
Huge kudos to the NCCN for officially incorporating prostate cancer into the Genetic/Familial High-Risk Assessment Guidelines. We've come a long way!
December 10, 2024 at 4:05 PM
Huge kudos to the NCCN for officially incorporating prostate cancer into the Genetic/Familial High-Risk Assessment Guidelines. We've come a long way!
Reposted
This Christmas and every year I remember my current and past patients with ornaments on our tree. Have been fortunate to care for thousands in my ten year career in oncology. Hope to help thousands more in the years to come. 🎄🕯️
December 26, 2024 at 2:10 AM
This Christmas and every year I remember my current and past patients with ornaments on our tree. Have been fortunate to care for thousands in my ten year career in oncology. Hope to help thousands more in the years to come. 🎄🕯️
Reposted
Reposted
Launching #AUC3 in Miami, consensus across kidney and bladder cancers. From small steps to significant scientific advances that change our patients’ lives. @drchoueiri.bsky.social #MontyPal #RanaMcKay #JonathanRosenberg
January 23, 2025 at 1:35 PM
Launching #AUC3 in Miami, consensus across kidney and bladder cancers. From small steps to significant scientific advances that change our patients’ lives. @drchoueiri.bsky.social #MontyPal #RanaMcKay #JonathanRosenberg
Reposted
#BrianShuch kicks us off, local #kidneycancer heterogeneous - guppies, goldfish and sharks! Integrating staging & biomarkers to help us evaluate risk and prognosis. #AUC3
January 23, 2025 at 2:01 PM
#BrianShuch kicks us off, local #kidneycancer heterogeneous - guppies, goldfish and sharks! Integrating staging & biomarkers to help us evaluate risk and prognosis. #AUC3
Reposted
Drs. #NaomiHaas #HansHammers debate locally advanced #kidneycancer and use of periop immunotherapy. Grading, staging, and prediction of risk/benefit leads to rigorous shared decision making with our patients. @drchoueiri.bsky.social #AUC3
January 23, 2025 at 2:40 PM
Drs. #NaomiHaas #HansHammers debate locally advanced #kidneycancer and use of periop immunotherapy. Grading, staging, and prediction of risk/benefit leads to rigorous shared decision making with our patients. @drchoueiri.bsky.social #AUC3
Reposted
#BrianRini & #MikeAtkins debate refractory #kidneycancer management after IO front line or adjuvant PD1 inhibitor. Do we rechallenge? Yes likely after a certain time point (6 vs 12 months debated). #AUC3
January 23, 2025 at 7:10 PM
#BrianRini & #MikeAtkins debate refractory #kidneycancer management after IO front line or adjuvant PD1 inhibitor. Do we rechallenge? Yes likely after a certain time point (6 vs 12 months debated). #AUC3
Reposted
Great milestone 🎯🥇 for #mCRC treatment #GIonc #OncSky based on the last update clinicaltrials.gov/study/NCT046... FDA grants Accelerated Approval to Encorafenib Plus Cetuximab and Chemo for BRAF V600E+ Metastatic Colorectal Cancer www.fda.gov/drugs/resour...
ClinicalTrials.gov
clinicaltrials.gov
December 21, 2024 at 8:20 AM
Great milestone 🎯🥇 for #mCRC treatment #GIonc #OncSky based on the last update clinicaltrials.gov/study/NCT046... FDA grants Accelerated Approval to Encorafenib Plus Cetuximab and Chemo for BRAF V600E+ Metastatic Colorectal Cancer www.fda.gov/drugs/resour...
Reposted
🔍 Does AI reduce #clinician workload?
@NEJM study on @NuanceDragon DAX Copilot, an AI-powered documentation tool, found minimal impact on EHR efficiency & financial metrics❗️
💡AI tools need to be developed in comjuction with 🩺🥼🧑⚕️ not in silos
#AIinMedicine #LLMs @oncoalert.bsky.social
@NEJM study on @NuanceDragon DAX Copilot, an AI-powered documentation tool, found minimal impact on EHR efficiency & financial metrics❗️
💡AI tools need to be developed in comjuction with 🩺🥼🧑⚕️ not in silos
#AIinMedicine #LLMs @oncoalert.bsky.social
December 21, 2024 at 5:17 AM
🔍 Does AI reduce #clinician workload?
@NEJM study on @NuanceDragon DAX Copilot, an AI-powered documentation tool, found minimal impact on EHR efficiency & financial metrics❗️
💡AI tools need to be developed in comjuction with 🩺🥼🧑⚕️ not in silos
#AIinMedicine #LLMs @oncoalert.bsky.social
@NEJM study on @NuanceDragon DAX Copilot, an AI-powered documentation tool, found minimal impact on EHR efficiency & financial metrics❗️
💡AI tools need to be developed in comjuction with 🩺🥼🧑⚕️ not in silos
#AIinMedicine #LLMs @oncoalert.bsky.social
Congratulations @n8pennell.bsky.social and all elected members @ascocancer.bsky.social
Congratulations to @n8pennell.bsky.social @clevelandclinic.bsky.social for being elected to the @ascocancer.bsky.social board of Directors! @oncoalert.bsky.social so proud my colleague!
December 23, 2024 at 12:39 AM
Congratulations @n8pennell.bsky.social and all elected members @ascocancer.bsky.social
Reposted
“Why are we listening to men & not women?” asks Dr @narjustflorezmd.bsky.social of @florezlab.bsky.social
This question & the increase in #lungcancer diagnoses among younger women vs men are the genesis for the #HearHer campaign.
Read more & help us change this👇
healio.com/news/hematolog…#LCSMSM
This question & the increase in #lungcancer diagnoses among younger women vs men are the genesis for the #HearHer campaign.
Read more & help us change this👇
healio.com/news/hematolog…#LCSMSM
December 22, 2024 at 1:38 PM
“Why are we listening to men & not women?” asks Dr @narjustflorezmd.bsky.social of @florezlab.bsky.social
This question & the increase in #lungcancer diagnoses among younger women vs men are the genesis for the #HearHer campaign.
Read more & help us change this👇
healio.com/news/hematolog…#LCSMSM
This question & the increase in #lungcancer diagnoses among younger women vs men are the genesis for the #HearHer campaign.
Read more & help us change this👇
healio.com/news/hematolog…#LCSMSM
Reposted
Interesting article studying oncologist’s decision-making from a psychosocial perspective:
#Oncologists exposed to scenarios of a “nice” or “demanding” pt were associated with less recommendations of chemotherapy near the #EOL .
#heme/onc #lcsm #lcam #oncsky #medsky
doi.org/10.1093/onco...
#Oncologists exposed to scenarios of a “nice” or “demanding” pt were associated with less recommendations of chemotherapy near the #EOL .
#heme/onc #lcsm #lcam #oncsky #medsky
doi.org/10.1093/onco...
Patients’ psychosocial attributes and aggressiveness of cancer treatments near the end of life
AbstractBackground. While the use of chemotherapy near the end of life (EOL) has been identified as a relevant criterion for assessing quality of cancer ca
doi.org
December 22, 2024 at 11:32 AM
Interesting article studying oncologist’s decision-making from a psychosocial perspective:
#Oncologists exposed to scenarios of a “nice” or “demanding” pt were associated with less recommendations of chemotherapy near the #EOL .
#heme/onc #lcsm #lcam #oncsky #medsky
doi.org/10.1093/onco...
#Oncologists exposed to scenarios of a “nice” or “demanding” pt were associated with less recommendations of chemotherapy near the #EOL .
#heme/onc #lcsm #lcam #oncsky #medsky
doi.org/10.1093/onco...
Reposted
Reposted
Key takeaways:
•The #HearHer campaign focuses on gender disparities in lung cancer diagnosis and clinical trial enrollment.
•Clinicians should take women’s concerns seriously and make use of imaging for early detection.
Article here: www.healio.com/news/hematol...
•The #HearHer campaign focuses on gender disparities in lung cancer diagnosis and clinical trial enrollment.
•Clinicians should take women’s concerns seriously and make use of imaging for early detection.
Article here: www.healio.com/news/hematol...
December 22, 2024 at 5:55 PM
Key takeaways:
•The #HearHer campaign focuses on gender disparities in lung cancer diagnosis and clinical trial enrollment.
•Clinicians should take women’s concerns seriously and make use of imaging for early detection.
Article here: www.healio.com/news/hematol...
•The #HearHer campaign focuses on gender disparities in lung cancer diagnosis and clinical trial enrollment.
•Clinicians should take women’s concerns seriously and make use of imaging for early detection.
Article here: www.healio.com/news/hematol...
Reposted
🧵 Real world effectiveness study using #EHR from 20 health systems: #COVID19 vaccination ⬇️ risk of #longCOVID in kids/adolescents during Delta & Omicron waves. Mediation analysis suggests effectiveness is indirect, via ⬇️ the risk of #SARSCoV2 infection. #MedTwitter #MedSky
December 8, 2024 at 4:31 PM
🧵 Real world effectiveness study using #EHR from 20 health systems: #COVID19 vaccination ⬇️ risk of #longCOVID in kids/adolescents during Delta & Omicron waves. Mediation analysis suggests effectiveness is indirect, via ⬇️ the risk of #SARSCoV2 infection. #MedTwitter #MedSky
Reposted
Link to the original study examining real world effectiveness of #COVID19 vaccination in reducing risk of #LongCovid in kids & adolescents here: www.thelancet.com/action/showP....
#MedSky #IDSky #Pediatrics #GetVaccinated
#MedSky #IDSky #Pediatrics #GetVaccinated
www.thelancet.com
December 8, 2024 at 4:35 PM
Link to the original study examining real world effectiveness of #COVID19 vaccination in reducing risk of #LongCovid in kids & adolescents here: www.thelancet.com/action/showP....
#MedSky #IDSky #Pediatrics #GetVaccinated
#MedSky #IDSky #Pediatrics #GetVaccinated
Stayed active during 17-hour flight from SEA->Singapore :-) Looking forward to present TROPiCS04 phase 3 trial data at #ESMOASIA on Dec 7 ~10am local time discussed by Dr. Friedlander @oncoalert.bsky.social @achoud72.bsky.social @erplimackmd.bsky.social @valdesan.bsky.social @fredhutch.bsky.social
December 6, 2024 at 11:21 AM
Stayed active during 17-hour flight from SEA->Singapore :-) Looking forward to present TROPiCS04 phase 3 trial data at #ESMOASIA on Dec 7 ~10am local time discussed by Dr. Friedlander @oncoalert.bsky.social @achoud72.bsky.social @erplimackmd.bsky.social @valdesan.bsky.social @fredhutch.bsky.social
Reposted
Thank you Mirrors of Medicine & dear Colleagues
#PROSCA24 #BLADDR24 & #RENALC24
FINAL STATS with OVER 21 million impression on X
SHOUT OUT TO Our Ambassadors Specially
@drnataliagandur.bsky.social
@barbaramelao.bsky.social
@pgrivasmdphd.bsky.social
@achoud72.bsky.social
#PROSCA24 #BLADDR24 & #RENALC24
FINAL STATS with OVER 21 million impression on X
SHOUT OUT TO Our Ambassadors Specially
@drnataliagandur.bsky.social
@barbaramelao.bsky.social
@pgrivasmdphd.bsky.social
@achoud72.bsky.social
December 2, 2024 at 2:13 PM
Thank you Mirrors of Medicine & dear Colleagues
#PROSCA24 #BLADDR24 & #RENALC24
FINAL STATS with OVER 21 million impression on X
SHOUT OUT TO Our Ambassadors Specially
@drnataliagandur.bsky.social
@barbaramelao.bsky.social
@pgrivasmdphd.bsky.social
@achoud72.bsky.social
#PROSCA24 #BLADDR24 & #RENALC24
FINAL STATS with OVER 21 million impression on X
SHOUT OUT TO Our Ambassadors Specially
@drnataliagandur.bsky.social
@barbaramelao.bsky.social
@pgrivasmdphd.bsky.social
@achoud72.bsky.social
As we return from Thanksgiving Holidays we are grateful for everyone’s hard work & @ASCO mission to support providers & patients! Would like to remind active members to participate in @ASCO election-stellar candidates across all categories-Deadline: Dec 3rd 3pm EST
society.asco.org/about-asco/a...
society.asco.org/about-asco/a...
ASCO Election
ASCO Election
society.asco.org
December 2, 2024 at 12:44 AM
As we return from Thanksgiving Holidays we are grateful for everyone’s hard work & @ASCO mission to support providers & patients! Would like to remind active members to participate in @ASCO election-stellar candidates across all categories-Deadline: Dec 3rd 3pm EST
society.asco.org/about-asco/a...
society.asco.org/about-asco/a...